Welcome!

News Feed Item

Mania Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Mania Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256138/Mania-Global-Clinical-Trials-Review-H2-2014.html

Mania Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Mania Global Clinical Trials Review, H2, 2014" provides data on the Mania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mania. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mania. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6

Mania 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mania to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mania to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Mania 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Mania Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
AstraZeneca PLC 32

Clinical Trial Overview of AstraZeneca PLC 32
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Abbott Laboratories 35
Clinical Trial Overview of Abbott Laboratories 35
Johnson & Johnson 36
Clinical Trial Overview of Johnson & Johnson 36
Otsuka Holdings Co., Ltd. 37
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Richter Gedeon Nyrt. 39

Clinical Trial Overview of Richter Gedeon Nyrt. 39
Actavis plc 40
Clinical Trial Overview of Actavis plc 40
Bristol-Myers Squibb Company 41
Clinical Trial Overview of Bristol-Myers Squibb Company 41
Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Top Institutes / Government 43
Massachusetts General Hospital 43
Clinical Trial Overview of Massachusetts General Hospital 43
University of Cincinnati 44
Clinical Trial Overview of University of Cincinnati 44
Mclean Hospital 45
Clinical Trial Overview of Mclean Hospital 45
University of Leipzig 46

Clinical Trial Overview of University of Leipzig 46
Cedars-Sinai Medical Center 47
Clinical Trial Overview of Cedars-Sinai Medical Center 47
University of British Columbia 48
Clinical Trial Overview of University of British Columbia 48
Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
National Institute of Mental Health 50
Clinical Trial Overview of National Institute of Mental Health 50
University of Texas Southwestern Medical Center at Dallas 51
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 51
Mashhad University of Medical Sciences 52
Clinical Trial Overview of Mashhad University of Medical Sciences 52
Five Key Clinical Profiles 53
Appendix 114
Abbreviations 114
Definitions 114
Research Methodology 115
Secondary Research 115
About GlobalData 116
Contact Us 116
Disclaimer 116
Source 116

List of Tables

Mania Therapeutics, Global, Clinical Trials by Region, 2014* 7
Mania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mania Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Mania Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Mania Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Mania Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Mania Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Mania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mania Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mania Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Mania Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Mania Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Mania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mania Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Mania Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Mania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Mania Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Mania Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Mania Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Mania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 32
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 35
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 36
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 37

Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Richter Gedeon Nyrt., 2014* 39
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 40
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 41
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 42
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 43
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 44
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 45
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2014* 46
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2014* 47
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 48

Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 49
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 50
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 51
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014* 52

List of Figures

Mania Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Mania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mania Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Mania Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Mania Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Mania Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Mania Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Mania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mania Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mania Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Mania Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Mania Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Mania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Mania Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Mania Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Mania Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Mania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 115

To order this report: Mania Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256138/Mania-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
When you focus on a journey from up-close, you look at your own technical and cultural history and how you changed it for the benefit of the customer. This was our starting point: too many integration issues, 13 SWP days and very long cycles. It was evident that in this fast-paced industry we could no longer afford this reality. We needed something that would take us beyond reducing the development lifecycles, CI and Agile methodologies. We made a fundamental difference, even changed our culture...
@ThingsExpo has been named the ‘Top WebRTC Influencer' by iTrend. iTrend processes millions of conversations, tweets, interactions, news articles, press releases, blog posts - and extract meaning form them and analyzes mobile and desktop software platforms used to communicate, various metadata (such as geo location), and automation tools. In overall placement, @ThingsExpo ranked as the number one ‘WebRTC Influencer' followed by @DevOpsSummit at 55th.
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
@DevOpsSummit taking place June 6-8, 2017 at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @DevOpsSummit at Cloud Expo New York Call for Papers is now open.
"There's a growing demand from users for things to be faster. When you think about all the transactions or interactions users will have with your product and everything that is between those transactions and interactions - what drives us at Catchpoint Systems is the idea to measure that and to analyze it," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York Ci...
In a recent research, analyst firm IDC found that the average cost of a critical application failure is $500,000 to $1 million per hour and the average total cost of unplanned application downtime is $1.25 billion to $2.5 billion per year for Fortune 1000 companies. In addition to the findings on the cost of the downtime, the research also highlighted best practices for development, testing, application support, infrastructure, and operations teams.
"Avere Systems is a hybrid cloud solution provider. We have customers that want to use cloud storage and we have customers that want to take advantage of cloud compute," explained Rebecca Thompson, VP of Marketing at Avere Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Dataloop.IO, an innovator in cloud IT-monitoring whose products help organizations save time and money, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Dataloop.IO is an emerging software company on the cutting edge of major IT-infrastructure trends including cloud computing and microservices. The company, founded in the UK but now based in San Fran...
Updating DevOps to the latest production data slows down your development cycle. Probably it is due to slow, inefficient conventional storage and associated copy data management practices. In his session at @DevOpsSummit at 20th Cloud Expo, Dhiraj Sehgal, in Product and Solution at Tintri, will talk about DevOps and cloud-focused storage to update hundreds of child VMs (different flavors) with updates from a master VM in minutes, saving hours or even days in each development cycle. He will also...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
SYS-CON Events announced today that Linux Academy, the foremost online Linux and cloud training platform and community, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Linux Academy was founded on the belief that providing high-quality, in-depth training should be available at an affordable price. Industry leaders in quality training, provided services, and student certification passes, its goal is to c...
The unique combination of Amazon Web Services and Cloud Raxak, a Gartner Cool Vendor in IT Automation, provides a seamless and cost-effective way of securely moving on-premise IT workloads to Amazon Web Services. Any enterprise can now leverage the cloud, manage risk, and maintain continuous security compliance. Forrester's analysis shows that enterprises need automated security to lower security risk and decrease IT operational costs. Through the seamless integration into Amazon Web Services, ...
In the next five to ten years, millions, if not billions of things will become smarter. This smartness goes beyond connected things in our homes like the fridge, thermostat and fancy lighting, and into heavily regulated industries including aerospace, pharmaceutical/medical devices and energy. “Smartness” will embed itself within individual products that are part of our daily lives. We will engage with smart products - learning from them, informing them, and communicating with them. Smart produc...
"We provide DevOps solutions. We also partner with some key players in the DevOps space and we use the technology that we partner with to engineer custom solutions for different organizations," stated Himanshu Chhetri, CTO of Addteq, in this SYS-CON.tv interview at DevOps at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Providing the needed data for application development and testing is a huge headache for most organizations. The problems are often the same across companies - speed, quality, cost, and control. Provisioning data can take days or weeks, every time a refresh is required. Using dummy data leads to quality problems. Creating physical copies of large data sets and sending them to distributed teams of developers eats up expensive storage and bandwidth resources. And, all of these copies proliferating...